Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudiue

Acta Neuropathologica

Volumn 92, Issue 2, 1996, Pages 138-149

  Schröder, J Michael ^a   Kaldenbach, Titus ^a   Piroth, Werner ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

AIDS; Mitochondria; Myopathy; Nucleus; Zidovudine

Indexed keywords

ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELL ULTRASTRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; FETUS; HETEROCHROMATIN; MITOCHONDRION; MITOCHONDRION SWELLING; MUSCLE CELL; MYOPATHY; NERVE CELL CULTURE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SPINAL CORD; SPINAL GANGLION;

ANIMALS; CELL NUCLEUS; COCULTURE TECHNIQUES; GANGLIA, SPINAL; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; ZIDOVUDINE;

EID: 0030004222     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050501     Document Type: Article

References (72)

1. Altaian J, Bayer SA (1984) The development of the rat spinal cord. Adv Anat Embryol Cell Biol 85: 1-164
2. Anderson TD, Davidovich A, Arceo R, Brosnan C, Arezzo J, Schaumburg H (1992) Peripheral neuropathy induced by 2′,2′-dedeoxycytidine. Lab Invest 66: 63-74
3. Anderson TD, Davidovich A, Feldman D, Sprinkle TJ, Arezzo J, Brosnan C, Calderon RO, Fossom LH, DeVries JT, DeVries GH (1994) Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab Invest 70: 724-739
4. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508-510
5. Avramis VI, Markson W, Jackson RL, Gomperts E (1989) Biochemical pharmacology of zidovudine in human T-lymphoblastoid cell (CEM). AIDS 3: 417-422
6. Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clerko E, Broder S, Johns DG (1988) The in vitro and in vivo antiretrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species, Biochem Pharmacol 37: 897-903
7. Barré-Sinoussi F, Chermann JC, Rey R, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Brun-Vézinet F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotrophic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871
8. Bessen LJ, Greene JB, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318: 708
9. Bhalla K, Birkhofer M, Grant S, Graham G (1989) The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) in 3′-azido-3′-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 17: 17-20
10. Bolden A, Noy GP, Weissbach A (1977) DNA polymerase of mitochondria is a gamma-polymerase. J Biol Chem 252: 3352-3356
11. Byars N, Kidson C (1975) DNA chain termination by 2′,3′-dideoxythymidine in replicating mammalian cells. Biochemistry 14: 3159-3164
12. Chariot P, Bonne G, Authier F-J, Marsac C, Gherardi R (1994) Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy. J Neurosci 125: 190-193
13. Cheng Y-C, Dutschman GE, Bastow KF, Sarngadharan MG, Ting RYC (1987) Human immunodeficiency reverse transcriptase. J Biol Chem 262: 2187-2189
14. Cornford ME, Ho HW, Vinters HV (1992) Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment. Acta Neuropathol 84: 516-529
15. Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC (1995) Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. Acta Neuropathol 90: 1-6
16. Dalakas MC, Pezeshkpour GH (1988) Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol 23 [Suppl]: S38-S48
17. Dalakas MC, Ilia I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322: 1098-1105
18. Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon, De Truchis P, Leport C, Bouvet E, Pazza MC, Levacher M, Regnier B (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet II: 1297-1302
19. Feldman D, Anderson TD (1994) Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2′,3′-dideoxycytidine. Acta Neuropathol 87: 71-80
20. Feldman D, Brosnan C, Anderson TD (1992) Ultrastructure of peripheral neuropathy induced in rabbits by 2′,3′-dideoxycytidine. Lab Invest 66: 75-85
21. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Scooley RT, Jackson GG, Durack DT, King D (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317: 185-191
22. Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction with human immunodeficiency reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337
23. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TL, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503
24. Gertner E, Thurn JR, Williams DN, Simpson M, Belfour HH, Rhame F, Henry K (1988) Zidovudine-associated myopathy. Am J Med 86: 814-818
25. Ghadially FN (1988) Ultrastructural pathology of the cell and matrix, 3rd edn, vol 1. Butterworths, London, pp 1-158
26. Gherardi RK, Florea-Strat A, Fromont G, Poron F, Sabourin J-C, Autier J (1994) Cytokine expression in the muscle of HIV-infected patients: evidence of interleukin-1 accumulation in mitochondria of AZT fibers. Ann Neurol 36: 752-758
27. Gorard DA, Henry K, Giloff RJ (1988) Necrotizing myopathy and zidovudine. Lancet I: 1050
28. Hagler DN, Frame PT (1986) Azidothymidine neurotoxicity (letter). Lancet II: 1392-1393
29. Helbert M, Fletcher T, Peddle B, Harris JRW, Pinching AJ (1988) Zidovudine-associated myopathy. Lancet II: 689-690
30. Herzberg N, Zorn I, Zwart R, Portegies P, Bolhuis P (1992) Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine. Muscle Nerve 15: 706-710
31. Huang P, Farquhar D, Plunkett W (1990) Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases. J Biol Chem 265: 11914-11918
32. Jézéquel AM, Shreeve MM, Steiner JW (1967) Segregation of nucleolar components in mycoplasma-infected cells. Lab Invest 16: 287-304
33. Kahn J, Lagakos S, Richman D, Cross A, Pettinelli C, Liou S-H, Brown M, Volberding P, Crumpacker C, Beall G, Sacks H, Merigan T, Beltangady M, Smaldone L, Dolin R, the NIAID AIDS Clinical Trials Group (1992) A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 327: 581-587
34. Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R (1991) Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 65: 742-751
35. Lane RJM, McLean KA, Moss J, Woodrow DF (1993) Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathol Appl Neurobiol 19:406-413
36. Lange DJ, Rubin M, Britton CB, Hays AP, Younger DS (1990) Disorders of peripheral nerves associated with HIV infection. Clin Pediatr Med Surg 7: 71-81
37. Lewis W, Gonzalez B, Chomyn A, Papoian T (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89: 1354-1360
38. MacDonell, Murphy R, Sahgal V, Skoutelis A, Phair JP (1989) Myopathy associated with HIV infection and zidovudine therapy. CDC AIDS Weekly 16: 23
39. Matthes E, Lehman C, Scholz D, Janta-Lipinski M von, Gaertner K, Rosenthal HA, Langen P (1987) Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular polymerases alpha and beta. Biochem Biophys Res Commun 148: 78-85
40. Melamed AJ, Muller RJ, Gold JWM, Wise Campbell S, Kleinberg ML, Armstrong D (1987) Possible zidovudine-induced hepatoxicity (letter). JAMA 258: 2063
41. Mhiri C, Baudriment M, Bonne G, Geny, Degoul F, Marsac C, Roullet E, Gherardi R (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29: 606-614
42. Morgello S, Wolfe D, Godfrey E, Feinstein R, Tagliati M, Simpson DM (1995) Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol 90: 366-374
43. Munch-Petersen B (1988) Azidothymidine inhibits mitogen stimulated growth and DNA-repair in human peripheral lymphocytes. Biochem Biophys Res Commun 157: 1369-1375
44. Panegyres PK, Tan N, Kakulas BA, Armstrong JA (1988) Necrotizing myopathy and zidovudine. Lancet I: 1050-1051
45. Panegyres PK, Papadimitriou JM, Hollingsworth PN, Armstrong JA, Kakulas BA (1990) Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment. J Neurol Neurosurg Psychiatry 53: 649-655
46. Parker WB, White EL, Shaddix SC, Ross LJ, Buckheit RW, Germany JM, Secrist JA, Vince R, Shannon WM (1991) Mechanism of inhibition of human immunodeficiency virus type I reverse transcriptase and human DNA-polymerases alpha, beta and gamma by the 5′-triphosphates of carbovir, 3′-azido-3′-deoxythymidine. 2′,3′-dideoxyguanosine. and 3′-deoxythymidine. J Biol Chem 266: 1754-1762
47. Popovic M, Sarnpadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and preAIDS. Science 224: 497-500
48. Reddy J, Svoboda D (1968) The relationship of nucleolar segregation to ribonucleic acid synthesis following the administration of selected hepatocarcinogens. Lab Invest 19: 132-145
49. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S (1987) The toxicity of azidothymidine (AZT) in treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317: 192-197
50. Scanlon KJ, Kashani-Sabet M, Sowers LC (1989) Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine. Cancer Commun 1: 269-275
51. Schröder JM (1982) Pathologie der Muskulatur. In: Doerr J, Seifert G, Uehlinger E (eds) Spezielle pathologische Anatomie, vol 15. Springer, Berlin Heidelberg New York, pp 444-454
52. Schröder JM, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39-47
53. Scovassi AI, Wicker R, Bertazzoni U (1979) A phylogenetic study on vertebrate mitochondrial DNA polymerase. Eur J Biochem 100: 491-496
54. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch MA, Feinberg J, Dafni U, AIDS Clinical Trials Group (1993) Zidovudine treatment of AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 33: 343-349
55. Simpson DM, Olney RK (1992) Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 10: 685-711
56. Simpson MV, Chin CD, Keilbaugh SA, Lin T-S, Prusoff WH (1989) Studies on the inhibition of mitochondrial DNA-replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-I replication. Biochem Pharmacol 38: 1033-1036
57. Sistori C, Bosisio M (1966) Oncolysis by herpes simplex. Lancet I: 96
58. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency synrome: analysis of 50 patients. Ann Neurol 14: 403-418
59. Sommadossi J-P, Carlisle R (1987) Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro. Antimicrob Agents Chemother 31: 452-454
60. Sommadossi J-P, Carlisle R, Zhou Z (1989) Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36: 9-14
61. St Clair MH, Richards CA, Spector T, Weinhold KJ, Miller WH, Langlois AJ, Furman PA (1987) 3′-Azido-3′-deoxyihymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother 31: 1972-1977
62. Stern R, Gold J, DiCarlo EF (1987) Myopathy complicating the acquired immune deficiency syndrome. Muscle Nerve 10: 318-322
63. Swanson JL, Craighead JE, Reynolds ES (1966) Electron microscopic observations of herpes virus hominis (herpes simplex virus) encephalitis in man. Lab Invest 15: 1966-1981
64. Till M, MacDonell KB (1990) Myopathy with human immunodeficiency virus type I (HIV-1) infection: HIV-1 or zidovudine? Ann Intern Med 113: 492-494
65. Tischner KH, Schröder JM (1972) The effects of cadmium chloride on organotypic cultures of rat sensory ganglia. A light and electron microscopic study. J Neurol Sci 16: 383-399
66. Tyrsted G (1984) Effect of 5-fluoro-2′-deoxyuridine and hydroxyurea on the phytohemagglutinin-induced increase of thymidine kinase, replicative DNA polymerase, deoxycytidylate deaminase, and CDP reductase activity in human lymphocytes. Mol Cell Biochem 62: 165-174
67. Weidner DA, Sommadossi J-P (1990) 3′-Azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-962 human leukemia cells. Mol Pharmacol 38: 797-804
68. Weiss M, Meyer J (1972) Comparison of the effects of Coxsackie virus A9 and of actinomycin D on the nucleolar ultrastructure of the monkey kidney cells. J Ultrastruct Res 38: 411-419
69. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC (1989) HTLV-I myositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 320: 992-995
70. Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Kim Lyerly H, Durack DT, Gelmann E, Nusinoff Lehrman S, Blum RM, Barry DW, Shearer GM, Fischl MA, Mitsuya H, Gallo RC, Collins JM, Bolognesi DP, Myers CE, Broder S (1986) Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet I: 575-580
71. Yoshida Y, Yoshida C (1990) Reversal of azidothymidine-induced bone-marrow suppression by 2′,3′-dideoxythymidine as studied by hematopoietic clonal culture. AIDS Res Hum Retroviruses 6: 929-932
72. Zhu Z, Carlisle R, Sommadossi J-P (1988) Studies on mechanism of toxicity of 3′-azido-3′-deoxythymidine (AZT) in human bone marrow (HBM) cells, Intersci Conf Antimicrob Agents Chemother 28: 1466